Fibrin Sealant VH S/D 500 S-apr in Hepatic Resection

PHASE2CompletedINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

November 30, 2010

Primary Completion Date

July 31, 2011

Study Completion Date

July 31, 2011

Conditions
Bleeding (Oozing) in Hepatic Resection
Interventions
DRUG

Fibrin Sealant (FS) VH S/D 500 s-apr

Dosage form: spray application; dosage frequency: single application

OTHER

Manual compression

Dosage form: surgical gauze swab; dosage frequency: single application

Trial Locations (7)

Unknown

Berlin

Essen

Hanover

Heidelberg

Jena

Leipzig

Tübingen

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Baxter Innovations GmbH

INDUSTRY

lead

Baxter Healthcare Corporation

INDUSTRY

NCT01244425 - Fibrin Sealant VH S/D 500 S-apr in Hepatic Resection | Biotech Hunter | Biotech Hunter